Laminar Pharma Alternatives & Competitors
12 companies similar to Laminar Pharma — Biopharmaceutical company performing discovery, rational design and initial clin...
Companies similar to Laminar Pharma
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
San Diego, United States
SignalChem Lifesciences Corporation (SLC)
Drug discovery focused on developing novel small molecule kinase inhibitors for the treatm...
Richmond, Canada
Oslo, Norway
Actuate Therapeutics, Inc.
Pioneering advancements in the fight against high-impact cancers and neurodegenerative dis...
Rival Readout
Competing with Laminar Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Nanoligent
Our mision is to improve the life of patients by designing new drugs that selectively targ...
Spain
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology (Nasdaq: LIXT)
United States
Cytoki Pharma
Leveraging lipidated IL-22 to treat metabolic diseases and IBD
Denmark
Arvinas
Leading the way in targeted protein degradation therapeutics
New Haven, United States
Crossbow Therapeutics, Inc
Established antibody engineering to target the untapped universe of intracellular cancer t...
Cambridge, United States
Alterome Therapeutics, Inc
To Life!
San Diego, United States
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
About Laminar Pharma
Laminar Pharma, established in 2006, is a pioneering entity within the Biotechnology, Life Sciences, and Pharmaceutical sectors. Based out of Spain, this biopharmaceutical company is making waves with its focus on the groundbreaking "Membrane-Lipid Therapy" (MLT). This innovative approach targets membrane lipids to mod...
Design and development of drugs based on melitherapy, Conducting clinical trials, Providing expanded access policies for drug therapies, Collaboration with scientific and medical communities
Patients with unmet medical needs, Healthcare providers, Pharmaceutical investors, Scientific and clinical research professionals
Biopharmaceutical, Membrane-Lipid Therapy, Drug Discovery, Rational Drug Design, Clinical Development, Cancer Treatment, CNS Disorders, Inflammatory Diseases, Metabolic Diseases, Peripheral Proteins, Signal Transduction Modulation, Glioblastoma Treatment, Neurodegenerative Diseases, Spin-off, Therapeutic Strategy
B2B, White Label
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Laminar Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Laminar Pharma on 8 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
